Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2005-9-26
pubmed:abstractText
Rebamipide, a gastromucosal protective drug, suppresses indomethacin-induced gastropathy in humans and rodents. Effects of rebamipide on gene expression in indomethacin-treated gastric mucosal cells (RGM1) were investigated using high-density oligonucleotide arrays. Indomethacin induced apoptosis in RGM1 cells in a dose-dependent manner. Rebamipide pretreatment significantly reduced indomethacin-induced apoptosis. We used gene expression profiling on high-density oligonucleotide probe arrays to characterize the transcriptional response of RGM1 cells to indomethacin treatment for 6 hr. Of the 8,799 probes examined, 717 (8.1%) were induced (400 probes) or repressed (317 probes) at least 1.5-fold. Among the 158 genes that were induced by indomethacin at least 2.0-fold, four genes that were down-regulated by rebamipide at least 2.0-fold are listed: growth arrest and DNA-damage-inducible 45 alpha (GADD 45 alpha), golgi SNAP receptor complex member 1, iodothyronine deiodinases, and transcription factor 8. Real time-PCR confirmed GADD 45 alpha expression and its inhibition by rebamipide. Inhibition of apoptosis-related genes is possibly important for the cytoprotective effect of rebamipide against indomethacin-induced gastric mucosal cell injury.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0163-2116
pubmed:author
pubmed:issnType
Print
pubmed:volume
50 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S104-12
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:16184411-Alanine, pubmed-meshheading:16184411-Animals, pubmed-meshheading:16184411-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:16184411-Anti-Ulcer Agents, pubmed-meshheading:16184411-Apoptosis, pubmed-meshheading:16184411-Cell Culture Techniques, pubmed-meshheading:16184411-Cell Cycle Proteins, pubmed-meshheading:16184411-DNA Damage, pubmed-meshheading:16184411-Dose-Response Relationship, Drug, pubmed-meshheading:16184411-Down-Regulation, pubmed-meshheading:16184411-Gastric Mucosa, pubmed-meshheading:16184411-Gene Expression Profiling, pubmed-meshheading:16184411-Indomethacin, pubmed-meshheading:16184411-Nuclear Proteins, pubmed-meshheading:16184411-Oligonucleotide Probes, pubmed-meshheading:16184411-Polymerase Chain Reaction, pubmed-meshheading:16184411-Quinolones, pubmed-meshheading:16184411-Rats
pubmed:year
2005
pubmed:articleTitle
Rebamipide, a gastro-protective drug, inhibits indomethacin-induced apoptosis in cultured rat gastric mucosal cells: association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression.
pubmed:affiliation
Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan. ynaito@koto.kpu-m.ac.jp
pubmed:publicationType
Journal Article